Institution
Imperial College London
Education•London, Westminster, United Kingdom•
About: Imperial College London is a education organization based out in London, Westminster, United Kingdom. It is known for research contribution in the topics: Population & Medicine. The organization has 90019 authors who have published 209164 publications receiving 9337534 citations. The organization is also known as: Imperial College of Science, Technology and Medicine & Imperial College.
Topics: Population, Medicine, Context (language use), Cancer, Computer science
Papers published on a yearly basis
Papers
More filters
TL;DR: It is argued that much of the most needed 'structural HIV prevention' is unavoidably political in that it calls for community actions and structural changes within a broad framework concerned to alleviate inequity in health, welfare and human rights.
927 citations
TL;DR: The pipeline is described in detail, following a brief overview of UK Biobank brain imaging and the acquisition protocol and several quantitative investigations carried out as part of the development of both the imaging protocol and the processing pipeline.
927 citations
University of Marburg1, University of Erlangen-Nuremberg2, Rovira i Virgili University3, University of Göttingen4, Max Planck Society5, University of California, Los Angeles6, International School for Advanced Studies7, University of Melbourne8, University of Trieste9, Ikerbasque10, University of Toronto11, Nanyang Technological University12, National Institutes of Health13, Stanford University14, Shanghai Jiao Tong University15, Tongji University16, University of Seville17, Karolinska Institutet18, Drexel University19, Sichuan University20, Rice University21, Northwestern University22, University of Basel23, Zhejiang University24, Heidelberg University25, University of Tokyo26, Harvard University27, University of Utah28, University of Michigan29, Swiss Federal Laboratories for Materials Science and Technology30, Seoul National University31, Saarland University32, Columbia University33, Chinese Academy of Sciences34, Kazan Federal University35, Emory University36, University of California, Irvine37, Autonomous University of Barcelona38, University of Massachusetts Amherst39, Pennsylvania State University40, Ghent University41, Imperial College London42, National Tsing Hua University43, South China University of Technology44, University of Ulm45, Hebrew University of Jerusalem46, Huazhong University of Science and Technology47, Peking University48
TL;DR: An overview of recent developments in nanomedicine is provided and the current challenges and upcoming opportunities for the field are highlighted and translation to the clinic is highlighted.
Abstract: The design and use of materials in the nanoscale size range for addressing medical and health-related issues continues to receive increasing interest. Research in nanomedicine spans a multitude of areas, including drug delivery, vaccine development, antibacterial, diagnosis and imaging tools, wearable devices, implants, high-throughput screening platforms, etc. using biological, nonbiological, biomimetic, or hybrid materials. Many of these developments are starting to be translated into viable clinical products. Here, we provide an overview of recent developments in nanomedicine and highlight the current challenges and upcoming opportunities for the field and translation to the clinic.
926 citations
TL;DR: The receding horizon control strategy as mentioned in this paper provides a relatively simple method for determining feedback control for linear or nonlinear systems and is especially useful for the control of slow non-linear systems, such as chemical batch processes, where it is possible to solve, sequentially, open-loop fixed-horizon, optimal control problems online.
Abstract: The receding horizon control strategy provides a relatively simple method for determining feedback control for linear or nonlinear systems. The method is especially useful for the control of slow nonlinear systems, such as chemical batch processes, where it is possible to solve, sequentially, open-loop fixed-horizon, optimal control problems online. The method has been shown to yield a stable closed-loop system when applied to time-invariant or time-varying linear systems. It is shown that the method also yields a stable closed-loop system when applied to nonlinear systems. >
926 citations
Ikerbasque1, University of the Basque Country2, Carlos III Health Institute3, University of Salamanca4, National Health Service5, University of Manchester6, Imperial College London7, Mayo Clinic8, Sapienza University of Rome9, University of Copenhagen10, University of Glasgow11, University of Regensburg12, Yale University13, University of Padua14, University of Edinburgh15, University of Minnesota16, Marche Polytechnic University17, University of Rennes18, University of Paris19, University of Florence20, University of Milano-Bicocca21, University of Zurich22, Erasmus University Rotterdam23, University of Barcelona24
TL;DR: This expert Consensus Statement, endorsed by the ENS-CCA, summarizes the latest advances in CCA, including classification, genetics and treatment, and provides recommendations for CCA management and priorities across basic, translational and clinical research.
Abstract: Cholangiocarcinoma (CCA) includes a cluster of highly heterogeneous biliary malignant tumours that can arise at any point of the biliary tree Their incidence is increasing globally, currently accounting for ~15% of all primary liver cancers and ~3% of gastrointestinal malignancies The silent presentation of these tumours combined with their highly aggressive nature and refractoriness to chemotherapy contribute to their alarming mortality, representing ~2% of all cancer-related deaths worldwide yearly The current diagnosis of CCA by non-invasive approaches is not accurate enough, and histological confirmation is necessary Furthermore, the high heterogeneity of CCAs at the genomic, epigenetic and molecular levels severely compromises the efficacy of the available therapies In the past decade, increasing efforts have been made to understand the complexity of these tumours and to develop new diagnostic tools and therapies that might help to improve patient outcomes In this expert Consensus Statement, which is endorsed by the European Network for the Study of Cholangiocarcinoma, we aim to summarize and critically discuss the latest advances in CCA, mostly focusing on classification, cells of origin, genetic and epigenetic abnormalities, molecular alterations, biomarker discovery and treatments Furthermore, the horizon of CCA for the next decade from 2020 onwards is highlighted
926 citations
Authors
Showing all 90798 results
| Name | H-index | Papers | Citations |
|---|---|---|---|
| Albert Hofman | 267 | 2530 | 321405 |
| David Miller | 203 | 2573 | 204840 |
| Tamara B. Harris | 201 | 1143 | 163979 |
| Mark I. McCarthy | 200 | 1028 | 187898 |
| Peter J. Barnes | 194 | 1530 | 166618 |
| Simon D. M. White | 189 | 795 | 231645 |
| Patrick W. Serruys | 186 | 2427 | 173210 |
| John Hardy | 177 | 1178 | 171694 |
| Simon Baron-Cohen | 172 | 773 | 118071 |
| Richard H. Friend | 169 | 1182 | 140032 |
| Yang Gao | 168 | 2047 | 146301 |
| Hongfang Liu | 166 | 2356 | 156290 |
| Philippe Froguel | 166 | 820 | 118816 |
| Salvador Moncada | 164 | 495 | 138030 |
| Dennis R. Burton | 164 | 683 | 90959 |